APA (7th ed.) Citation

Porter, J., Bowden, D. K., Economou, M., Troncy, J., Ganser, A., Habr, D., . . . Cappellini, M. D. (2012). Health-Related Quality of Life, Treatment Satisfaction, Adherence and Persistence in β-Thalassemia and Myelodysplastic Syndrome Patients with Iron Overload Receiving Deferasirox: Results fromthe EPIC Clinical Trial. Anemia (20901267), 1. https://doi.org/10.1155/2012/297641

Chicago Style (17th ed.) Citation

Porter, John, et al. "Health-Related Quality of Life, Treatment Satisfaction, Adherence and Persistence in β-Thalassemia and Myelodysplastic Syndrome Patients with Iron Overload Receiving Deferasirox: Results Fromthe EPIC Clinical Trial." Anemia (20901267) 2012: 1. https://doi.org/10.1155/2012/297641.

MLA (9th ed.) Citation

Porter, John, et al. "Health-Related Quality of Life, Treatment Satisfaction, Adherence and Persistence in β-Thalassemia and Myelodysplastic Syndrome Patients with Iron Overload Receiving Deferasirox: Results Fromthe EPIC Clinical Trial." Anemia (20901267), 2012, p. 1, https://doi.org/10.1155/2012/297641.